We tested for remarkable Elk-1 and/or pElk-1 protein in the classic brain regions undergoing clinically significant neuronal loss in either human Lewy Body disease (e.g. Parkinson's Disease), Alzheimer's disease (AD), or Huntington's Disease (HD). This evidence concerns the gene ELK1 and Alzheimer disease.